Anuradha Krishnamurthy, MBBS, discusses the exciting frontier of tumor-infiltrating lymphocyte therapy in melanoma and other disease states.

It started with a dull ache in my right shoulder. At first, I chalked it up to bad posture or sleeping funny. Then came a ...

NovoCure's Q1 beat, Optune Lua momentum, and global expansion signal strong growth ahead. Find out why NVCR stock is a buy.

Many investors love the "big mo." That's short for "big momentum." Stocks that are on a roll often keep the good times going.